ABSTRACT

Solid tumours continue to be a foremost public health issue, with severe million of new cases and millions of deaths related to cancer per year. Several treatment plans are currently being investigated to advance this terrible disease. Therapy outcomes improve as a cancer diagnosis progresses; however, patient recovery remains difficult. Nanomedicine is advent as a cutting-edge and promising alternative technology has a number of advantages over traditional cancer medicines, and it opens up new avenues for cancers early recognition and diagnostics. Despite malignancy nanomedicines' potential to deliver chemotherapeutic agents at the target site, it is critical to examine the complexity of cancer as well as the dynamics to bridge the gap between bench-to-bedside